Mount Sinai Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (16)

2024

  1. Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma

    Cancer Epidemiology, Vol. 92

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Protective ileostomy creation after anterior resection of the rectum: Shared decision-making or still subjective?

    Colorectal Disease, Vol. 25, Núm. 4, pp. 647-659

2022

  1. Lung Spatial Profiling Reveals a T Cell Signature in COPD Patients with Fatal SARS-CoV-2 Infection

    Cells, Vol. 11, Núm. 12

2021

  1. KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma

    Blood Cancer Journal, Vol. 11, Núm. 6

  2. Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance

    Journal of Clinical Oncology, Vol. 39, Núm. 25, pp. 2779-2790

2020

  1. A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma

    Leukemia, Vol. 34, Núm. 12, pp. 3298-3309

  2. Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas: An International Multicenter Study of 318 Cases

    The Journal of bone and joint surgery. American volume, Vol. 102, Núm. 19, pp. 1703-1713

2019

  1. Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

    The Lancet Haematology, Vol. 6, Núm. 9, pp. e448-e458

  2. Perspectives on Directions and Priorities for Future Preclinical Studies in Regenerative Medicine

    Circulation Research, Vol. 124, Núm. 6, pp. 938-951

  3. The global burden of pulmonary diseases: Most prevalent problems and opportunities for improvement

    Annals of Global Health

2017

  1. Intertumoral Heterogeneity within Medulloblastoma Subgroups

    Cancer Cell, Vol. 31, Núm. 6, pp. 737-754.e6

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

2014

  1. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

2012

  1. Detectable clonal mosaicism and its relationship to aging and cancer

    Nature Genetics, Vol. 44, Núm. 6, pp. 651-658

2003

  1. This house believes that opioid rotation is useful in palliative settings

    Current Oncology